国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Sclerotinia sclerotiorum Type 1 phosphatases regulator ypi1 (ypi1) CSB-YP412292STG
CSB-EP412292STG
CSB-BP412292STG
CSB-MP412292STG
CSB-EP412292STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum ATP-dependent RNA helicase dbp3 (dbp3), partial CSB-YP412293STG
CSB-EP412293STG
CSB-BP412293STG
CSB-MP412293STG
CSB-EP412293STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Tethering factor for nuclear proteasome sts1 (sts1) CSB-YP412294STG
CSB-EP412294STG
CSB-BP412294STG
CSB-MP412294STG
CSB-EP412294STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Probable beta-galactosidase C (lacC), partial CSB-YP412295STG
CSB-EP412295STG
CSB-BP412295STG
CSB-MP412295STG
CSB-EP412295STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Probable zinc metalloprotease SS1G_12596 (SS1G_12596), partial CSB-YP412296STG
CSB-EP412296STG
CSB-BP412296STG
CSB-MP412296STG
CSB-EP412296STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Formation of crista junctions protein 1 (fcj1), partial CSB-YP412297STG1
CSB-EP412297STG1
CSB-BP412297STG1
CSB-MP412297STG1
CSB-EP412297STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Neutral protease 2 homolog SS1G_13741 (SS1G_13741) CSB-YP412298STG
CSB-EP412298STG
CSB-BP412298STG
CSB-MP412298STG
CSB-EP412298STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum 3-ketoacyl-CoA reductase (SS1G_14012), partial CSB-YP412299STG1
CSB-EP412299STG1
CSB-BP412299STG1
CSB-MP412299STG1
CSB-EP412299STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum ATP-dependent RNA helicase dbp7 (dbp7), partial CSB-YP412300STG
CSB-EP412300STG
CSB-BP412300STG
CSB-MP412300STG
CSB-EP412300STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Plasma membrane fusion protein prm1 (prm1), partial CSB-YP412301STG1
CSB-EP412301STG1
CSB-BP412301STG1
CSB-MP412301STG1
CSB-EP412301STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Aspartate--ammonia ligase (asnA) CSB-YP412302YAN
CSB-EP412302YAN
CSB-BP412302YAN
CSB-MP412302YAN
CSB-EP412302YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Probable molybdopterin-guanine dinucleotide biosynthesis protein A (mobA) CSB-YP412303YAN
CSB-EP412303YAN
CSB-BP412303YAN
CSB-MP412303YAN
CSB-EP412303YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP412304YAN
CSB-EP412304YAN
CSB-BP412304YAN
CSB-MP412304YAN
CSB-EP412304YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP412305YAN
CSB-EP412305YAN
CSB-BP412305YAN
CSB-MP412305YAN
CSB-EP412305YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Phosphopantetheine adenylyltransferase (coaD) CSB-YP412306YAN
CSB-EP412306YAN
CSB-BP412306YAN
CSB-MP412306YAN
CSB-EP412306YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Protein-export protein secB (secB) CSB-YP412307YAN
CSB-EP412307YAN
CSB-BP412307YAN
CSB-MP412307YAN
CSB-EP412307YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Regulator of ribonuclease activity A (rraA) CSB-YP412308YAN
CSB-EP412308YAN
CSB-BP412308YAN
CSB-MP412308YAN
CSB-EP412308YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L31 (rpmE) CSB-YP412309YAN
CSB-EP412309YAN
CSB-BP412309YAN
CSB-MP412309YAN
CSB-EP412309YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Acetylglutamate kinase (argB) CSB-YP412310YAN
CSB-EP412310YAN
CSB-BP412310YAN
CSB-MP412310YAN
CSB-EP412310YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase (gppA) CSB-YP412311YAN
CSB-EP412311YAN
CSB-BP412311YAN
CSB-MP412311YAN
CSB-EP412311YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>